Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

827
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
827
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

885
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
885
Long-term Depression01:05

Long-term Depression

33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
Long-term Depression01:03

Long-term Depression

3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K
Depression: Overview01:18

Depression: Overview

1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trigeminal root dislocation subtends focal demyelination of primary trigeminal afferents in patients with trigeminal neuralgia.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Linking wetlands to relatively permanent flowing waters: a conterminous United States geospatial analysis.

Wetlands ecology and management·2026
Same author

Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.

Frontiers in psychiatry·2025
Same author

Sleep Macrostructure, Cyclic Alternating Pattern and CSF Cytokines in De Novo Relapsing-Remitting Multiple Sclerosis: A Controlled Polysomnographic Study.

Journal of sleep research·2025
Same author

Erythroid-stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort.

British journal of haematology·2025
Same author

Therapeutic approach to fibromyalgia: a consensus statement on pharmacological and non-pharmacological treatment from the neuropathic pain special interest group of the Italian neurological society.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025

Related Experiment Video

Updated: Mar 15, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K

Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian

C Solaro1, E Trabucco1,2, A Signori3

  • 1Neurology Unit, Head and Neck Dept., ASL 3 "Genovese", Genoa, Italy.

Plos One
|September 16, 2016
PubMed
Summary

Depressive symptoms affect 30% of multiple sclerosis (MS) patients. The Beck Depression Inventory II (BDI II) score correlates with disability and disease course in MS, especially in secondary progressive MS.

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K

Area of Science:

  • Neurology
  • Psychiatry
  • Clinical Research

Background:

  • Depression is highly prevalent in multiple sclerosis (MS), affecting up to 50% of patients.
  • Understanding the factors associated with depression in MS is crucial for effective management.
  • The Beck Depression Inventory II (BDI II) is a widely used tool for assessing depressive symptoms.

Purpose of the Study:

  • To determine the prevalence of depressive symptoms in a multicenter MS population.
  • To explore correlations between BDI II scores and demographic/clinical variables in MS patients.
  • To evaluate the utility of the BDI II in identifying depression in MS.

Main Methods:

  • A multicenter, cross-sectional study was conducted across six Italian MS centers.
  • The Beck Depression Inventory II (BDI II) was administered to assess depressive symptoms.
  • Data from 1,011 MS patients were analyzed for demographic and clinical correlations.

Main Results:

  • 33.9% of MS patients scored above the 14 cut-off on the BDI II, indicating depressive symptoms.
  • Higher BDI II scores correlated significantly with disability (EDSS) and disease course.
  • Depressive symptoms were particularly noted in patients with secondary progressive (SP) MS compared to primary progressive (PP) MS.

Conclusions:

  • Approximately 30% of the studied MS population exhibited depressive symptoms based on BDI II scores.
  • The BDI II is a valuable tool for screening depressive symptoms in individuals with MS.
  • BDI II scores provide insights into the relationship between depression, disability, and disease progression in MS.